Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study

BACKGROUND: Evidence for pharmacogenetic risk stratification of angiotensin-converting enzyme inhibitor (ACEI) treatment is limited. Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two pharmacogenetic scores that previously...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Nelveg-Kristensen, Karl Emil, Busk Madsen, Majbritt, Torp-Pedersen, Christian, Køber, Lars, Egfjord, Martin, Berg Rasmussen, Henrik, Riis Hansen, Peter
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669156/
https://ncbi.nlm.nih.gov/pubmed/26633885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144195
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi